TOP > 外国特許検索 > Method of using cell-free protein synthesis to produce a membrane protein

Method of using cell-free protein synthesis to produce a membrane protein UPDATE 実績あり

外国特許コード F190009902
整理番号 07366-US
掲載日 2019年8月26日
出願国 アメリカ合衆国
出願番号 74157508
公報番号 20100291189
公報番号 8226976
出願日 平成20年11月5日(2008.11.5)
公報発行日 平成22年11月18日(2010.11.18)
公報発行日 平成24年7月24日(2012.7.24)
国際出願番号 JP2008070116
国際公開番号 WO2009060857
国際出願日 平成20年11月5日(2008.11.5)
国際公開日 平成21年5月14日(2009.5.14)
優先権データ
  • 特願2007-286899 (2007.11.5) JP
  • 2008JP70116 (2008.11.5) WO
発明の名称 (英語) Method of using cell-free protein synthesis to produce a membrane protein UPDATE 実績あり
発明の概要(英語) A method is provided for producing a membrane protein folded to its native structure or active structure in a lipid disc or a liposome. The method comprises: (a) preparing a reaction solution for cell-free protein synthesis containing a polynucleotide encoding a membrane protein, a steroidal detergent, and a phospholipid, wherein the steroidal detergent is contained at a concentration higher than its critical micelle concentration; (b) decreasing the concentration of said steroidal detergent in the reaction solution; and (c) synthesizing the membrane protein simultaneously with formation of a lipid disk or liposome into which the synthesized membrane protein is integrated.
従来技術、競合技術の概要(英語) BACKGROUND
Primary structures of proteins encoded by genome in various organisms have been revealed based on results of various genome projects. Approximately 30% of proteins in higher organisms have been presumed to be an endogenous membrane protein (integral membrane protein) having transmembrane helix. Membrane proteins are involved in signal transduction, mass transportation, energy production, formation of cytoskeleton etc. at cell membranes. In addition, the membrane protein is very important as a potential drug target. Actually, it is known that approximately 70% of commercially available pharmaceutical agents act on membrane proteins, especially on a G protein-coupled receptor. Protein 3000 Project in Japan which was conducted in consideration of the importance of protein structures has revealed stereostructures of more proteins than was initially expected and produced internationally great results. However, there are merely a few cases that have revealed the stereostructures of membrane proteins, since it is difficult to produce crystals of membrane proteins suitable for structural analysis.
The applicant of the present application has already developed a method for producing an insoluble protein using a cell-free protein synthesis system in the presence of detergent (surfactant) without the protein being insolubilized (see, for example, Patent Document 1 and Non-Patent Document 1). This method can be merely applied to a case where various membrane proteins can be abundantly synthesized as soluble fraction and a case where a detergent used does not inhibit protein synthesis. Accordingly, there are some detergents that cannot be selected for the method as those which contribute to the stabilization of the synthesized protein.
Moreover, a method for synthesizing a membrane protein having a biological function by merely adding a lipid liposome to a cell-free protein synthesis system is also reported (see Patent Document 2 and Non-Patent Document 2). However, it is considered that the method is not necessarily versatile, since the introducibility of membrane proteins into a liposome depends on their respective properties and the probability of contact between a synthesized polypeptide chain and a liposome is low.
- [Patent Document 1] Japanese Patent Kokai Publication No. 2003-18999A
- [Patent Document 2] Japanese Patent Kokai Publication No. 2005-225796A
- [Non-Patent Document 1] Ishihara G. et al., (2005) Protein Expression and Purification, Vol. 41, pp. 27-37
- [Non-Patent Document 2] Kalmbach, R. et al., (2007) Journal of Molecular Biology, Vol. 371, pp. 639-648
特許請求の範囲(英語) [claim1]
1. A method for producing a membrane protein folded to its native or active structure in a lipid disk or liposome, comprising:
(a) preparing a reaction solution for cell-free protein synthesis containing a polynucleotide encoding a membrane protein, a steroidal detergent, and a phospholipid, wherein the steroidal detergent is contained at a concentration higher than its critical micelle concentration,
(b) decreasing the concentration of said steroidal detergent in the reaction solution, and
(c) synthesizing the membrane protein simultaneously with formation of a lipid disk or liposome into which the synthesized membrane protein is integrated.

[claim2]
2. The method of claim 1, wherein said membrane protein is synthesized by a cell-free protein synthesis reaction using a dialysis method, and said steroidal detergent is contained in the reaction solution at an initial concentration of 1.5 to 10 times higher than its critical micelle concentration.

[claim3]
3. The method of claim 1, wherein said steroidal detergent is digitonin, cholate or CHAPS.

[claim4]
4. The method of claim 1, wherein said reaction solution for cell-free protein synthesis contains 10 to 20 mg/ml sodium cholate at an initial concentration.

[claim5]
5. The method of claim 1, wherein said reaction solution for cell-free protein synthesis contains 5 to 10 mg/mL CHAPS at an initial concentration.

[claim6]
6. The method of claim 1, wherein said reaction solution for cell-free protein synthesis contains 1 to 4 mg/mL digitonin at an initial concentration.

[claim7]
7. The method of claim 1, wherein said (b) comprises adsorbing the detergent by using a resin capable of binding to the detergent.

[claim8]
8. The method of claim 1, wherein the membrane protein comprises a receptor protein, a channel protein, a transporter, a membrane-bound enzyme, or a partial sequence, a homologous sequence, a modified sequence and an inducible sequence thereof.

[claim9]
9. The method of claim 1, further comprising a step of solubilizing the membrane protein from the resultant complex with the lipid disk or liposome to purify the membrane protein.

[claim10]
10. A composition for screening a pharmaceutical agent, the composition comprising the membrane protein produced by the method of claim 1, the protein being in a state of being integrated into a lipid disk or liposome.
  • 発明者/出願人(英語)
  • Yokoyama Shigeyuki
  • Shimono Kazumi
  • Shirouzu Mikako
  • Goto Mie
  • RIKEN
国際特許分類(IPC)

PAGE TOP

close
close
close
close
close
close